Citigroup
AXLA

Citigroup’s Axcella Health Inc. Common Stock AXLA Stock Holding History

Citigroup’s Portfolio AXLA Stock Details AXLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-45
Closed -$5K – 6496
2021
Q1 		$5K Sell
45
-68
-60% -$9.59K ﹤0.01% 5920
2020
Q4 		$15K Buy
113
+84
+290% +$10.8K ﹤0.01% 6809
2020
Q3 		$3K Sell
29
-20
-41% -$2.46K ﹤0.01% 7253
2020
Q2 		$7K Sell
49
-50
-51% -$6.12K ﹤0.01% 7196
2020
Q1 		$8K Buy
99
+36
+57% +$3.69K ﹤0.01% 7138
2019
Q4 		$6K Buy
63
+60
+2,000% +$6.59K ﹤0.01% 7364
2019
Q3 		$0 Sell
3
-15
-83% -$2.78K ﹤0.01% 7861
2019
Q2 		$4K Buy
+18
New +$5.7K ﹤0.01% 7545

Other funds holding AXLA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ZIM
Zacks Investment Management Chicago, Illinois $12.5B AUM 29.36% 1-Year Est. Return

Citigroup's AXLA Position: Q2 2021 in Review

Citigroup sold out of Axcella Health Inc. Common Stock (AXLA) in Q2 2021, closing a stake of 45 shares — an estimated $5K sold.

Citigroup first reported a position in AXLA in Q2 2019 and held it in 8 quarters. The position peaked at $15K in Q4 2020. 38 funds tracked by Wall St. Rank hold AXLA as of Q2 2021.

  • Citigroup reported no remaining Axcella Health Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Citigroup sold 45 Axcella Health Inc. Common Stock shares in Q2 2021, an estimated $5K.
  • Citigroup first reported a position in Axcella Health Inc. Common Stock in Q2 2019 and held it in 8 quarters.
  • Citigroup's Axcella Health Inc. Common Stock position peaked at $15K in Q4 2020.
  • 38 funds tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q2 2021.

Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.